Handelsbanken Fonder’s Cidara Therapeutics CDTX Stock Holding History

Handelsbanken Fonder’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,000	Closed	-$1.32M	–	1500
2025 Q4	$1.32M	Buy	+6,000	New	+$970K	﹤0.01%	914

Handelsbanken Fonder's CDTX Position: Q1 2026 in Review

Handelsbanken Fonder sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 6,000 shares — an estimated $1.32M sold.

Handelsbanken Fonder first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.32M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Handelsbanken Fonder reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Handelsbanken Fonder sold 6,000 Cidara Therapeutics shares in Q1 2026, an estimated $1.32M.
Handelsbanken Fonder first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Handelsbanken Fonder's Cidara Therapeutics position peaked at $1.32M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Handelsbanken Fonder's 13F filing for Q1 2026, filed 28 Apr 2026.